Dialysis and renal transplantation are the only two therapeutic options offered to patients affected by end-stage kidney disease; however, neither treatment can be considered definitive. In fact, dialysis is able to replace only the filtration function of the kidney without substituting its endocrine and metabolic roles, and dramatically impacts on patient's quality of life. On the other hand, kidney transplantation is severely limited by the shortage of transplantable organs, the need for immunosuppressive therapies and a narrow half-life. Regenerative medicine approaches are promising tools aiming to improve this condition.

Peloso, A., Katari, R., Murphy, S., Zambon, J., Defrancesco, A., Farney, A., et al. (2015). Prospect for kidney bioengineering: Shortcomings of the status quo. EXPERT OPINION ON BIOLOGICAL THERAPY, 15(4), 547-558 [10.1517/14712598.2015.993376].

Prospect for kidney bioengineering: Shortcomings of the status quo

MANZIA, TOMMASO MARIA;ORLANDO, GIUSEPPE
2015-01-01

Abstract

Dialysis and renal transplantation are the only two therapeutic options offered to patients affected by end-stage kidney disease; however, neither treatment can be considered definitive. In fact, dialysis is able to replace only the filtration function of the kidney without substituting its endocrine and metabolic roles, and dramatically impacts on patient's quality of life. On the other hand, kidney transplantation is severely limited by the shortage of transplantable organs, the need for immunosuppressive therapies and a narrow half-life. Regenerative medicine approaches are promising tools aiming to improve this condition.
2015
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/18 - CHIRURGIA GENERALE
English
Con Impact Factor ISI
3D printing; bioartificial kidney; kidney bioengineering; kidney on a chip; kidney regeneration; regenerative medicine; stem cells
Peloso, A., Katari, R., Murphy, S., Zambon, J., Defrancesco, A., Farney, A., et al. (2015). Prospect for kidney bioengineering: Shortcomings of the status quo. EXPERT OPINION ON BIOLOGICAL THERAPY, 15(4), 547-558 [10.1517/14712598.2015.993376].
Peloso, A; Katari, R; Murphy, S; Zambon, J; Defrancesco, A; Farney, A; Rogers, J; Stratta, R; Manzia, Tm; Orlando, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/113062
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 30
social impact